How do target of rapamycin inhibitors (TOR-I) compare with antimetabolites (AM) for primary immunosuppression in kidney transplant recipients?

2020 ◽  
Author(s):  
Samira Bell
2008 ◽  
Vol 8 (7) ◽  
pp. 1384-1392 ◽  
Author(s):  
B. L. Kasiske ◽  
A. de Mattos ◽  
S. M. Flechner ◽  
L. Gallon ◽  
H.-U. Meier-Kriesche ◽  
...  

2012 ◽  
Author(s):  
Luciana TM Saturnino ◽  
Maria GB Ceccato ◽  
Mariangela L Cherchiglia ◽  
Eli lola G Andrade ◽  
Luiz Flavio C Giordano ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document